share_log

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

Moderna 的涨幅将超过 42%?以下是周一的其他 10 项目标价格变化
Benzinga Real-time News ·  2022/12/19 08:31
  • Morgan Stanley cut VTEX (NYSE:VTEX) price target from $7 to $5. Â Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
  • Keybanc cut Progyny, Inc. (NASDAQ:PGNY) price target from $55 to $45. Keybanc analyst Scott Schoenhaus maintained an Overweight rating on the stock. Progyny gained 4.1% to close at $31.83 on Friday.
  • SVB Leerink raised the price target on Roivant Sciences Ltd. (NASDAQ:ROIV) from $8 to $10. SVB Leerink analyst David Risinger maintained an Outperform rating on the stock. Roivant Sciences shares gained 1.1% to close at $7.32 on Friday.
  • Raymond James boosted W. P. Carey Inc. (NYSE:WPC) price target from $80 to $85. Raymond James analyst RJ Milligan maintained an Outperform rating on the stock. W. P. Carey shares fell 0.1% to $79.73 in pre-market trading.
  • Needham raised AtriCure, Inc. (NASDAQ:ATRC) price target from $55 to $58.. Needham analyst Mike Matson maintained a Buy rating on the stock. AtriCure shares fell 2.6% to close at $41.37 on Friday.
  • JP Morgan cut Glaukos Corporation (NYSE:GKOS) price target from $48 to $42. JP Morgan analyst Allen Gong upgraded the stock from Underweight to Neutral. Glaukos shares rose 0.8% to $42.83 in pre-market trading.
  • Jefferies raised Moderna, Inc. (NASDAQ:MRNA) price target from $170 to $275. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Moderna shares fell 6.7% to close at $193.29 on Friday.
  • Stifel boosted Xylem Inc. (NYSE:XYL) price target from $113 to $115. 170. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Xylem shares fell 0.6% to $109.27 in pre-market trading.
  • Piper Sandler raised ConocoPhillips (NYSE:COP) price target from $155 to $157. Piper Sandler analyst Ryan Todd maintained an Overweight rating on the stock. ConocoPhillips shares rose 1% to $111.50 in pre-market trading.
  • HC Wainwright & Co. boosted Astria Therapeutics, Inc. (NASDAQ:ATXS) price target from $13 to $20. HC Wainwright & Co. analyst Joseph Pantginis maintained the stock with a Buy rating. Astria Therapeutics shares jumped 4.8% to close at $11.81 on Friday.
  • Baird cut L3Harris Technologies, Inc. (NYSE:LHX) price target from $290 to $241. Baird analyst Peter Arment downgraded the stock from Outperform to Neutral. L3Harris Technologies shares fell 1.5% to $210.00 in pre-market trading.
  • 摩根士丹利剪VTEX(纽约证券交易所股票代码:VTEX)目标价从7美元下调至5美元。̂分析师摩根士丹利将该股评级从增持下调至持平。VTEX股价周五下跌4.9%,收于3.52美元。
  • KeyBanc切割Progyny公司(纳斯达克:PGNY)目标价从55美元降至45美元。KeyBanc分析师斯科特·舍恩豪斯维持对该股的增持评级。周五,Progyny上涨4.1%,收于31.83美元。
  • SVB Leerink将目标价上调至罗万特科技有限公司(纳斯达克:ROIV)从8美元跌至10美元。SVB Leerink分析师David·里辛格维持该股表现优于大盘的评级。Roivant Sciences股价上周五上涨1.1%,收于7.32美元。
  • 雷蒙德·詹姆斯提振W.P.凯里公司(纽约证券交易所代码:WPC)目标价从80美元降至85美元。Raymond James分析师RJ Milligan对该股维持表现优于大盘的评级。W.P.Carey股价在盘前交易中下跌0.1%,至79.73美元。
  • 李约瑟养大AtriCure,Inc.(纳斯达克:ATRC)目标价从55美元降至58美元Needham分析师Mike·马特森维持对该股的买入评级。AtriCure股价周五下跌2.6%,收于41.37美元。
  • 摩根大通降息格劳科斯公司(纽约证券交易所代码:GKOS)目标价从48美元降至42美元。摩根大通分析师Allen Gong将该股评级从减持上调至中性。Glaukos股价在盘前交易中上涨0.8%,至42.83美元。
  • 杰富瑞提出Moderna公司(纳斯达克)目标价从170美元降至275美元。杰富瑞分析师Michael Yee将该股评级从持有上调至买入。上周五,Moderna股价下跌6.7%,收于193.29美元。
  • Stifel得到提振木质部公司(纽约证券交易所代码:XYL)目标价从113美元降至115美元。170.Stifel分析师内森·琼斯将该股评级从买入下调至持有。在盘前交易中,XYLEM股价下跌0.6%,至109.27美元。
  • 派珀·桑德勒养大康菲石油(纽约证券交易所代码:COP)目标价从155美元降至157美元。Piper Sandler分析师瑞安·托德维持对该股的增持评级。在盘前交易中,康菲石油的股价上涨了1%,至111.50美元。
  • HC Wainwright&Co.股价上涨Astria治疗公司(纳斯达克:ATXS)目标价从13美元升至20美元。HC Wainwright&Co.分析师约瑟夫·潘特吉尼斯将该股评级维持为买入。Astria Treateutics股价周五跳涨4.8%,收报11.81美元。
  • Baird CutL3Harris技术公司(纽约证券交易所代码:LHX)目标价从290美元降至241美元。Baird分析师Peter Arment将该股评级从强于大盘下调至中性。在盘前交易中,L3Harris Technologies的股价下跌了1.5%,至210.00美元。

Check out this: 4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More

看看这个:内部人士正在买入4只便士股票:Getround、Corvus PharmPharmticals等

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发